13F

Stock

Adial Pharmaceuticals, Inc.

ADIL · held by 23 managers

Reported value

$763.9K

Holders

23

+0 new · −0 exited

Holders’ est. mark

−$25

Price effect on 2 books still in the name

Largest holder

$562K

ARMISTICE CAPITAL, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ARMISTICE CAPITAL, LLC2.55M$562KHeld
Citadel219.6K$48.3KHeld
Vanguard156K$34.3KHeld
GEODE CAPITAL MANAGEMENT, LLC155.7K$34.3KHeld
JANE STREET GROUP, LLC121.8K$26.8KHeld
NORTHERN TRUST CORP66K$14.5KHeld
XTX Topco Ltd52.1K$11.5KHeld
Manchester Capital Management LLC48.1K$10.6KHeld
BlackRock, Inc.27.8K$6.11KHeld
StoneX Group Inc.19.5K$4.28KHeld
TWO SIGMA SECURITIES, LLC17.1K$3.76KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP12.1K$2.66KHeld
PRIVATE MANAGEMENT GROUP INC10K$2.2KHeld
UBS Group AG9.17K$2.02KHeld
Tower Research Capital LLC (TRC)1.34K$295Held
SBI Securities Co., Ltd.1.16K$255Held
BANK OF AMERICA CORP /DE/205$45−$24Cut−$19
WELLS FARGO & COMPANY/MN160$35Held
HARBOUR INVESTMENTS, INC.99$22Held
Virtu Financial LLC63.8K$14Held
Abound Wealth Management27$6Held
MORGAN STANLEY9$2−$1Cut−$1
CITIGROUP INC1$0Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.